Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Issuer Symbol
-
XLO on Nasdaq
There are no Buy or Sell transactions made by SV7 Impact Medicine Fund LP since 12 Mar 2025
Holdings reported by SV7 Impact Medicine Fund LP for Xilio Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
1,613,632 |
$1,339,315 |
$0.8300 |
26 Oct 2021 |
Direct |
|
|
| Common Stock |
1,613,632 |
$1,339,315 |
$0.8300 |
26 Oct 2021 |
Indirect |
|
|
| Series B Convertible Preferred Stock |
0 |
|
|
26 Oct 2021 |
Direct |
Common Stock |
|
| Series B Convertible Preferred Stock |
0 |
|
|
26 Oct 2021 |
Indirect |
Common Stock |
|
| Series C Convertible Preferred Stock |
0 |
|
|
26 Oct 2021 |
Direct |
Common Stock |
|
| Series C Convertible Preferred Stock |
0 |
|
|
26 Oct 2021 |
Indirect |
Common Stock |
|
Transactions reported by SV7 Impact Medicine Fund LP for Xilio Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.